Mark Douglas Smith - Net Worth and Insider Trading
Mark Douglas Smith Net Worth
The estimated net worth of Mark Douglas Smith is at least $2 Million dollars as of 2025-04-26. Mark Douglas Smith is the Director of Jazz Pharmaceuticals PLC and owns about 6,888 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $763,190. Mark Douglas Smith is the Director of Phreesia Inc and owns about 30,653 shares of Phreesia Inc (PHR) stock worth over $758,662. Mark Douglas Smith is also the Director of Teladoc Health Inc and owns about 8,355 shares of Teladoc Health Inc (TDOC) stock worth over $60,156. Details can be seen in Mark Douglas Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Douglas Smith has not made any transactions after 2024-08-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Douglas Smith
Mark Douglas Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Douglas Smith owns 3 companies in total, including Phreesia Inc (PHR) , Teladoc Health Inc (TDOC) , and Jazz Pharmaceuticals PLC (JAZZ) .
Click here to see the complete history of Mark Douglas Smith’s form 4 insider trades.
Insider Ownership Summary of Mark Douglas Smith
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| PHR | Phreesia Inc | 2024-07-18 | director |
| TDOC | Teladoc Health Inc | 2024-08-15 | director |
| JAZZ | Jazz Pharmaceuticals PLC | 2023-12-04 | director |
Mark Douglas Smith Latest Holdings Summary
Mark Douglas Smith currently owns a total of 3 stocks. Among these stocks, Mark Douglas Smith owns 6,888 shares of Jazz Pharmaceuticals PLC (JAZZ) as of December 4, 2023, with a value of $763,190 and a weighting of 48.24%. Mark Douglas Smith owns 30,653 shares of Phreesia Inc (PHR) as of July 18, 2024, with a value of $758,662 and a weighting of 47.96%. Mark Douglas Smith also owns 8,355 shares of Teladoc Health Inc (TDOC) as of August 15, 2024, with a value of $60,156 and a weighting of 3.8%.
Latest Holdings of Mark Douglas Smith
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 2023-12-04 | 6,888 | 110.80 | 763,190 |
| PHR | Phreesia Inc | 2024-07-18 | 30,653 | 24.75 | 758,662 |
| TDOC | Teladoc Health Inc | 2024-08-15 | 8,355 | 7.20 | 60,156 |
Holding Weightings of Mark Douglas Smith
Mark Douglas Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Douglas Smith has made a total of 5 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 417 shares on December 4, 2023, which brought Mark Douglas Smith around $49,736.
According to the SEC Form 4 filings, Mark Douglas Smith has made a total of 4 transactions in Phreesia Inc (PHR) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Phreesia Inc is the sale of 7,000 shares on July 18, 2024, which brought Mark Douglas Smith around $175,000.
According to the SEC Form 4 filings, Mark Douglas Smith has made a total of 1 transactions in Teladoc Health Inc (TDOC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Teladoc Health Inc is the acquisition of 4,000 shares on August 15, 2024, which cost Mark Douglas Smith around $28,320.
Insider Trading History of Mark Douglas Smith
- 1
Mark Douglas Smith Trading Performance
GuruFocus tracks the stock performance after each of Mark Douglas Smith's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Douglas Smith is 30.45%. GuruFocus also compares Mark Douglas Smith's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Douglas Smith within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Douglas Smith's insider trading performs compared to the benchmark.
Performance of Mark Douglas Smith
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.59 |  | | | | |
| Relative Return to S&P 500(%) | 13.1 | | | | | |
Mark Douglas Smith Ownership Network
Ownership Network List of Mark Douglas Smith
Ownership Network Relation of Mark Douglas Smith
Mark Douglas Smith Owned Company Details
What does Phreesia Inc do?
Who are the key executives at Phreesia Inc?
Mark Douglas Smith is the director of Phreesia Inc. Other key executives at Phreesia Inc include SVP & Life Sciences David Linetsky , Chief Financial Officer Balaji Gandhi , and General Counsel & Secretary Allison C Hoffman .
Phreesia Inc (PHR) Insider Trades Summary
Over the past 18 months, Mark Douglas Smith made no insider transaction in Phreesia Inc (PHR). Other recent insider transactions involving Phreesia Inc (PHR) include a net sale of 112,177 shares made by David Linetsky , a net sale of 180,645 shares made by Evan Roberts , and a net sale of 93,354 shares made by Allison C Hoffman .
In summary, during the past 3 months, insiders sold 218,795 shares of Phreesia Inc (PHR) in total and bought 0 shares, with a net sale of 218,795 shares. During the past 18 months, 809,233 shares of Phreesia Inc (PHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 809,233 shares.
Phreesia Inc (PHR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Phreesia Inc Insider Transactions
Mark Douglas Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Douglas Smith. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark Douglas Smith's mailing address is: Purchase Ny 10577.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
